NO943101D0 - 2,6-methano-2H-quinolizine derivative as a 5-HT 3 receptor antagonist - Google Patents

2,6-methano-2H-quinolizine derivative as a 5-HT 3 receptor antagonist

Info

Publication number: NO943101D0
Authority: NO; Norway
Prior art keywords: methano; receptor antagonist; quinolizine derivative; quinolizine; derivative
Prior art date: 1992-02-24

Application number

NO943101A

Other languages

Norwegian (no)

Other versions

NO943101L (en

Inventor

Maurice Ward Gittos

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-24

Filing date

1994-08-23

Publication date

1994-08-23

1994-08-23 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1994-08-23 Publication of NO943101D0 publication Critical patent/NO943101D0/en

1994-08-23 Publication of NO943101L publication Critical patent/NO943101L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO943101A 1992-02-24 1994-08-23 2,6-methano-2H-quinolizine derivative as a 5-HT 3 receptor antagonist NO943101L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP92400474		1992-02-24
PCT/US1993/000880 WO1993017019A1 (en)	1992-02-24	1993-02-03	2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist

Publications (2)

Publication Number	Publication Date
NO943101D0 true NO943101D0 (en)	1994-08-23
NO943101L NO943101L (en)	1994-08-23

Family

ID=8211614

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO943101A NO943101L (en)	1992-02-24	1994-08-23	2,6-methano-2H-quinolizine derivative as a 5-HT 3 receptor antagonist

Country Status (14)

Country	Link
EP (1)	EP0628043A1 (en)
JP (1)	JPH07504192A (en)
KR (1)	KR100287933B1 (en)
AU (1)	AU675060B2 (en)
CA (1)	CA2130563C (en)
FI (1)	FI105917B (en)
HU (1)	HU216831B (en)
IL (1)	IL104821A (en)
MX (1)	MX9300948A (en)
NO (1)	NO943101L (en)
NZ (1)	NZ249346A (en)
TW (1)	TW226374B (en)
WO (1)	WO1993017019A1 (en)
ZA (1)	ZA931146B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2672500A (en)	1999-02-18	2000-09-04	Novartis Ag	Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (en)	2005-03-07	2019-05-27	Univ Chicago	Use of opioid antagonists to attenuate the proliferation and migration of endothelial cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE129153T1 (en) *	1988-02-23	1995-11-15	Merrell Dow Pharma	USE OF QUINOLICIN AND QUINOLIZINONE DERIVATIVES FOR THE PRODUCTION OF MEDICINAL PRODUCTS.
EP0517984A1 (en) *	1991-06-11	1992-12-16	Merrell Dow Pharmaceuticals Inc.	Derivatives of amide analogs of certain methano bridged quinolizines

1993
- 1993-02-03 JP JP5514868A patent/JPH07504192A/en active Pending
- 1993-02-03 WO PCT/US1993/000880 patent/WO1993017019A1/en not_active Ceased
- 1993-02-03 EP EP93904797A patent/EP0628043A1/en not_active Withdrawn
- 1993-02-03 KR KR1019940702945A patent/KR100287933B1/en not_active Expired - Lifetime
- 1993-02-03 CA CA002130563A patent/CA2130563C/en not_active Expired - Lifetime
- 1993-02-03 HU HU9402436A patent/HU216831B/en unknown
- 1993-02-03 NZ NZ249346A patent/NZ249346A/en not_active IP Right Cessation
- 1993-02-03 AU AU36034/93A patent/AU675060B2/en not_active Expired
- 1993-02-18 ZA ZA931146A patent/ZA931146B/en unknown
- 1993-02-19 TW TW082101189A patent/TW226374B/zh not_active IP Right Cessation
- 1993-02-22 MX MX9300948A patent/MX9300948A/en unknown
- 1993-02-22 IL IL10482193A patent/IL104821A/en not_active IP Right Cessation
1994
- 1994-08-23 FI FI943872A patent/FI105917B/en not_active IP Right Cessation
- 1994-08-23 NO NO943101A patent/NO943101L/en unknown

Also Published As

Publication number	Publication date
MX9300948A (en)	1993-08-01
FI943872A0 (en)	1994-08-23
TW226374B (en)	1994-07-11
WO1993017019A1 (en)	1993-09-02
FI943872L (en)	1994-08-23
ZA931146B (en)	1993-09-14
HU9402436D0 (en)	1994-10-28
CA2130563C (en)	1997-11-11
KR100287933B1 (en)	2001-05-02
HUT68249A (en)	1995-06-28
HU216831B (en)	1999-09-28
AU3603493A (en)	1993-09-13
IL104821A (en)	1997-01-10
CA2130563A1 (en)	1993-09-02
JPH07504192A (en)	1995-05-11
NZ249346A (en)	1995-10-26
AU675060B2 (en)	1997-01-23
NO943101L (en)	1994-08-23
FI105917B (en)	2000-10-31
KR950700297A (en)	1995-01-16
EP0628043A1 (en)	1994-12-14
IL104821A0 (en)	1993-06-10

Similar Documents

Publication	Publication Date	Title
DK0808312T3 (en)	2001-02-12	Indole derivatives as a 5-HT receptor antagonist
NO943348L (en)	1994-11-09	Condensed indole derivatives as 5HT4 receptor antagonists
FI943247L (en)	1994-07-07	Piperazine derivatives as 5-HT receptor antagonists
ATE201016T1 (en)	2001-05-15	PYRIMIDINDIONE, PYRIMIDINDRION, TRIAZINDIONE DERIVATIVES AS ALPHA-1 ADRENERGIC RECEPTOR ANTAGONISTS
DK0856001T3 (en)	2002-12-30	Pyrimidine derivatives as 5-HT 2C receptor antagonists
FI922222A7 (en)	1992-11-18	KOPPLINGSANORDNING, SOM FOERMAOR LAOSA SPINALOSTEOSYNTESFAESTANORDNINGAR
FI925615L (en)	1993-06-13	Stabilizerade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reductase-inhibitorfoerening
FI922143A7 (en)	1992-05-12	MUSCARIN RECEPTOR ANTAGONIST.
FI923281L (en)	1993-01-20	FOERBAETTRADE DESINFEKTIONSLOESNINGAR, SOM INNEHAOLLER VAETEPEROXID
FI961628A7 (en)	1996-04-12	Indole derivatives as NMDA antagonists
FI922235L (en)	1992-11-17	FOERFARANDE FOER FRAMSTAELLNING AV 3-AMINOPYRIDAZINDERIVAT, SOM VERKAR PAODET CENTRALA NERVSYSTEMET
AU2314195A (en)	1995-11-29	Benzofuran derivatives as d4 receptor antagonists
DK0854867T3 (en)	2002-12-02	Tetrahydroquinolines as NMDA Antagonists
DK0710230T3 (en)	1999-06-14	1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists
FI920735A7 (en)	1992-08-22	VATTENHALTIGA POLYMERDISPERSIONER SOM INNEHAOLLER ORGANISKA FOERENINGAR MED KARBONAT- OCH KARBONYLGRUPPER, LIKSOM DAERMED FRAMSTAELLDA MAOLNINGS-OCH YTBEHANDLINGSSYSTEM
FI951798A0 (en)	1995-04-13	Bentzofuran derivatives as 5-HT1-like receptor antagonists
NO985970D0 (en)	1998-12-18	Indoline derivatives useful as 5_HT-2C receptor antagonists
FI914453A7 (en)	1993-03-24	FOERFARANDE FOER KOMPRESSERING AV EN VIDEOBILD, SOM KODATS DIGITALISKT
FI943872A0 (en)	1994-08-23	2,6-methono-2H-quinolithine derivative as a 5-HT 3 receptor antagonist
NO985972D0 (en)	1998-12-18	Indoline derivatives useful as 5-HT-2C receptor antagonists
FI922903L (en)	1992-06-22	4-ACETOXYPIPERIDINE DERIVATIVES, DERAS FRAMSTAELLNINGSFOERFARANDE OCH ANVAENDNING SOM ANTAGONIST FOER MUSCARINA M-3 RECEPTORER.
NO974205L (en)	1997-11-13	Heterocyclic-substituted piperazine derivatives as tachykinin receptor antagonists
NO983656D0 (en)	1998-08-10	Heterocyclyl-ergoline derivatives as 5-HT1A receptor ligands
FI922346A7 (en)	1992-05-22	MUSCARIN RECEPTOR ANTAGONIST.
ZA9600758D (en)	1997-09-30	Idole derivatives as 5-ht receptor antagonist.